FDA Regulation of LDTs is Misguided; Requires Congressional Authorization Washington, D.C. – The American Clinical Laboratory Association (ACLA) today submitted comments urging the U.S. Food ... Read More
Washington, D.C.– The American Clinical Laboratory Association (ACLA) commends the inclusion of critically needed relief from looming Medicare payment cuts to clinical laboratory services in ... Read More
November is American Diabetes Month, a chance to bring awareness to the fundamental role of clinical laboratories in diagnosing and managing this chronic, progressive health ... Read More
Washington, D.C. – The American Clinical Laboratory Association’s (ACLA) President, Susan Van Meter, issued the following statement after the House Energy and Commerce Committee’s Health ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today issued the following statement after the U.S. Food and Drug Administration (FDA) released a proposed ... Read More
September 7, 2023 update: Based on discussions with ACLA and other key stakeholders, CMS has made the decision to withdraw the policy change referenced in the ... Read More
June is Men’s Health Month, an opportunity to focus on the many ways that recommended clinical laboratory testing is essential in assessing, addressing and managing ... Read More
Washington, D.C. – The American Clinical Laboratory Association has joined with more than 30 health care provider organizations to urge House and Senate leadership to protect ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today issued the following statement as the federal government’s formal declaration of a Public Health Emergency (PHE) ... Read More
